01672.HK
Ascletis Pharma Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 8.97
+10.13%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.29x
- Price / sales
- 7877.92x
- Price / cash flow
- -22.66x
Enterprise value
- Enterprise value
- HKD 6.1B
- EV / sales
- 5488.03x
- EV / EBITDA
- -7.97x
- EV / EBIT
- -7.80x
- Market cap
- HKD 8.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026